Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Repeat daily, or as directed by prescriber
Summary: Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, and glucagon) that, based on Phase 2 trial data, produces significant appetite suppression and progressive weight loss, alongside gastrointestinal side effects that are most prominent during dose escalation
Swirl gently, refrigerate, protect from light, use within 28 days
In children, the doctor will look to see whether the child holds his or her hands over the navel when asked where it hurts
BPC-157 Research Applications in UK Laboratory Research UK laboratory researchers working with BPC-157 typically apply the compound across four research application areas
US$ 23.73
US$ 22.40
US$ 23.49
US$ 28.93
US$ 20.75
